Mean cost per stay of potentially preventable adult inpatient stays by condition U.S. 2017

In 2017, the mean cost per stay of potentially preventable inpatient hospital stays for heart failure among U.S. adults was around 10,100 U.S. dollars. This statistic illustrates the mean cost per stay of potentially preventable adult inpatient hospital stays in the United States in 2017, by condition type.

Mean cost per stay of preventable adult inpatient hospital stays in the United States in 2017, by condition type (in U.S. dollars)

Characteristic	Mean cost per stay in U.S. dollars
Heart failure	10,100
Chronic obstructive pulmonary disease	8,800
Diabetes long-term complications	15,300
Diabetes short-term complications	7,400
Uncontrolled diabetes	6,700
Lower-extremity amputation among patients with diabetes	27,000
Hypertension	7,400
Asthma in younger adults	6,200
Community-acquired pneumonia	9,000
Urinary tract infection	6,700

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

June 2020

More information

Region

United States

Survey time period

2017

Age group

18 years and older

Supplementary notes

Number of stays and mean costs are rounded to the nearest hundred. Totals and costs for all conditions, chronic conditions (including the overall diabetes total), and acute conditions are based on Prevention Quality Indicator (PQI) composite measures. For these measures, an inpatient stay that meets the criteria for multiple components of the composite (i.e., multiple conditions) is counted only once. Consistent with the Agency for Healthcare Research and Quality PQIs, obstetric stays are excluded.

Unlike the other potentially preventable conditions, lower-extremity amputation among patients with diabetes was not identified by principal diagnosis. Thus, it was possible for an inpatient stay to meet the criteria for this condition and one of the other chronic or acute conditions. In most of these cases, the overlap was with another diabetes condition. Because of this overlap, totals and costs for individual diabetes conditions should not be summed to estimate the diabetes group total or aggregate costs.

Citation formats